Dr. Amber Amalia Smith is a Sacramento, California based neurologist who is specialized in Neurology. Active license number of Dr. Amber Amalia Smith is A90349 for Neurology in California. Her current practice location is 2315 Stockton Blvd, Sacramento. Patients can reach her at 916-734-3514 or can fax her at 916-734-6525. Dr. Amber Amalia Smith is M.D. in Neurology and her NPI number (Unique professional ID assigned by NPPES) is 1417938911. Dr. Amber Amalia Smith specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Amber Amalia Smith speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1417938911
NPI Enumeration Date:
10 Nov, 2005
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Amber Amalia Smith are as mentioned below.
License Number
Specialization
State
Status
A90349
Neurology
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Amber Amalia Smith 4860 Y St, Suite 3700 Sacramento, California
Zip:
95817-2307
Phone Number:
916-734-3514
Fax Number:
916-734-6525
Patients can reach Dr. Amber Amalia Smith at 2315 Stockton Blvd, Sacramento, California or can call to book an appointment on 916-734-3514.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.